Results 51 to 60 of about 611,964 (268)
Pediatric Blood &Cancer, EarlyView.ABSTRACT Introduction Adolescent siblings of children with cancer are at elevated risk for psychosocial problems. Unfortunately, various barriers such as limited family time and resources, conflicting schedules, and psychosocial staffing constraints at cancer centers hinder sibling access to support.
Christina M. Amaro +10 more
wiley +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Pediatric gastroenteropancreatic neuroendocrine neoplasms (GEP‐NENs) are extremely rare and clinically heterogeneous. Management has largely been extrapolated from adult practice. This European Standard Clinical Practice Guideline (ESCP), developed by the EXPeRT network in collaboration with adult NEN experts, provides (adult) evidence ...
Michaela Kuhlen +23 more
wiley +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Purpose Chemoimmunotherapy with irinotecan, temozolomide, and dinutuximab (I/T/DIN) has emerged as first‐line therapy for relapsed/refractory (r/r) high‐risk neuroblastoma (HRNB) in North America. Topotecan and cyclophosphamide (T/C) are often used in combination with dinutuximab in the setting of lack of response, progression, or incomplete ...
Benjamin J. Lerman +17 more
wiley +1 more source
Area of admission and short-term care: is it still possible after the COVID pandemic?
Italian Journal of MedicineDear Editor, Since 2011, the Internal Medical Unit of Ospedale dell’Angelo, Mestre, has been equipped with an area of eight beds which served as a short-stay unit called area di accoglimento e degenza breve (area of admission and short-term care, ADB ...
Francesco Serafini +2 more
doaj +1 more source
Clinical Course and Impact of Breaks in Therapy for Children With Relapsed/Refractory Solid Tumors
Pediatric Blood &Cancer, EarlyView.ABSTRACT Introduction Pediatric relapsed or refractory (R/R) solid tumors carry a dismal prognosis, and postrelapse patient experiences are not well described. We present postrelapse outcomes, including number of R/R events and subsequent therapy regimens.
Matthew T. McEvoy +5 more
wiley +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Hemoglobinopathies are prevalent globally; diagnosis is complex in high genetic admixture populations like Brazil. We report, in two pediatric siblings, the first documented cases in Brazil of heterozygosity for hemoglobin (Hb) O‐Arab with coinheritance of α‐thalassemia (αα/−α4.2; −α3.7/−α4.2), resulting in microcytic and hypochromic anemia ...
Elisângela de Souza Miranda Muynarsk +9 more
wiley +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Neuropsychological complications may impair the qualitative prognosis of patients with pediatric brain tumors. However, multifaceted evaluations cannot be conducted in all patients because they are time consuming and burdensome for patients.
Ami Tabata +9 more
wiley +1 more source
Characters and character cycles
Journal of the Mathematical Society of Japan, 1993 In this paper the author proves a conjecture of \textit{M. Kashiwara} [Adv. Stud. Pure Math. 14, 369-378 (1988; Zbl 0699.22024)] which we will explain briefly below. Let \(G_R\) be a connected real semisimple linear algebraic group, \(G_C\) its complexification, \(B\) a Borel subgroup of \(G_C\), \(X = G_C/B\) the corresponding flag manifold, \(K_R ...
openaire +3 more sources
, 1983 ʾΩς eἰπeῖν τῷήτορι μόνος ὁ τοῡ ῆθους ἀγών ἐστιν. ‘To all intents and purposes, the conflict of character is the rhetor's only conflict.’ Ps.-Dionysius, Art of Rhetoric The importance of character ( ēthos ) in oratory was very familiar both to the Attic orators and to the early teachers of rhetoric. It was important in three ways.
openaire +2 more sources
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Patients with high‐risk neuroblastoma who either are refractory to induction chemotherapy or relapse following multi‐modal treatment have a dismal prognosis. Based on data from the BEACON trial, since 2021 the UK national guidelines recommend bevacizumab, irinotecan, and temozolomide (BIT) for patients with relapsed/refractory ...
Thomas J. Jackson +20 more
wiley +1 more source